Suggested mechanisms for its tumor-suppressive ability include 1 directly binding and downregulating EGFR 32, 2 interfering with angiogenesis 33, and 3 inhibiting cell migration and growth by suppressing β catenin levels 17. This evidence concerns the gene EGFR and neoplasm.